Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

BACKGROUND AND PURPOSE: Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Stroke
Main Authors: Lee, Eun-Jae, Kwon, Sun U., Park, Jong-Ho, Kim, Yong-Jae, Hong, Keun-Sik, Yu, Sungwook, Hwang, Yang-Ha, Lee, Ji Sung, Lee, Juneyoung, Rha, Joung-Ho, Heo, Sung Hyuk, Ahn, Sung Hwan, Seo, Woo-Keun, Park, Jong-Moo, Lee, Ju-Hun, Kwon, Jee-Hyun, Sohn, Sung-Il, Jung, Jin-Man, Kim, Hahn Young, Kim, Eung-Gyu, Kim, Sung Hun, Cha, Jae-Kwan, Park, Man-Seok, Nam, Hyo Suk, Kang, Dong-Wha
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Stroke Society 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7005357/
https://ncbi.nlm.nih.gov/pubmed/32027796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5853/jos.2019.02551
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados